3[1]Ondetti M A,Rubin B,Cushman DW. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents[J]. Science, 1977,196: 441-444.
4[2]Ondetti M A,Cushman DW. Enzymes of the renin angiotensin system and their inhibitors[J].Annu Rev Biochem, 1982,51:283-308.
5[3]Cohen M L. Synthetic and fermentation-derived angiotensinconverting enzyme inhibitors[J].Annu Rev Pharmacol Toxicol,1985, 25: 307-323.
6[4]Leonetti G,Cuspidi C. Choosing the right ACE inhibitor-A guide to selection[J]. Drugs, 1995, 49(4): 516.
8[7]Unger T, Ganten D, Long RE. Converting enzyme inhibitors:antihypertensive drugs with unexpected mechanisms[J]. Trends in Pharmacol Sci, 1983, 4: 514-519.
9[8]Antonaccio MJ, Kerwin L. Pre-and post junctional inhibition of vascular sympathetic function by captopril in SHR, implication and antihypertensive actions of captopril[J]. Hypertension, 1981,3(3ptz): 154-162.
10[9]Dejonge A,Knape JT, Van Meel JCA, et al. Effect ofcaptopril on sympathetic neurotransmission in pithed normotensive rats[J].Eur J Pharmacol, 1983,88:231-240.
